Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
59:31
Anticoagulants in Older Adults
56:26
Navigating the 2024 PAD Guidelines
1:00:08
Women’s Health Considerations in Thrombosis Webinar
8:07
Current opinions on andexanet alfa
1:01:21
HOT TOPICS - ANNEXA-I Trial
1:00:34
An Update on Breast Cancer Pathology Webinar Recording - 12-9-21
32:51
Reversing oral anticoagulants with a focus on Andexanet Alfa
7:53